CARD11.md
... ...
@@ -5,6 +5,10 @@ link-citations: true
5 5
---
6 6
[[_TOC_]]
7 7
8
+## Overview
9
+
10
+Mutations in CARD11 were initially described as enriched in the ABC subgroup of DLBCL.[@lenzOncogenicCARD11Mutations2008]
11
+More recent data contradicts this association and has implicated CARD11 in FL and additional B-cell lymphomas including FL and MCL.[@morinFrequentMutationHistonemodifying2011; @wuGeneticHeterogeneityPrimary2016]
8 12
9 13
## Experimental Evidence
10 14
... ...
@@ -65,7 +69,5 @@ The functional effect of CARD11 mutations in DLBCL was explored in the original
65 69
66 70
[[include:mermaid_CARD11.md]]
67 71
68
-Mutations in CARD11 were initially described as enriched in the ABC subgroup of DLBCL.[@lenzOncogenicCARD11Mutations2008]
69
-More recent data contradicts this association and has implicated CARD11 in FL and additional B-cell lymphomas including FL and MCL.[@morinFrequentMutationHistonemodifying2011; @wuGeneticHeterogeneityPrimary2016]
70 72
71 73
## References
CARD4.md
... ...
@@ -5,11 +5,11 @@ link-citations: true
5 5
---
6 6
[[_TOC_]]
7 7
8
+## Overview
8 9
9 10
*CARD4 is now known as NOD1.*
10 11
11 12
12
-
13 13
## Relevance tier by entity
14 14
15 15
|Entity|Tier|Description |